Trastuzumab News and Research

RSS
Key metabolic changes found in patients with chemotherapy-related heart toxicity

Key metabolic changes found in patients with chemotherapy-related heart toxicity

New research shows significant gaps in deployment of 'coverage with evidence development'

New research shows significant gaps in deployment of 'coverage with evidence development'

Researchers develop DNA nanorobots that target breast cancer cells

Researchers develop DNA nanorobots that target breast cancer cells

Medication could mitigate side effects of chemotherapy for breast cancer patients

Medication could mitigate side effects of chemotherapy for breast cancer patients

CT scans used in cancer diagnostics can provide valuable clues to preventing heart problems

CT scans used in cancer diagnostics can provide valuable clues to preventing heart problems

New identified biomarker predicts patients who might benefit from HER2-targeted agents

New identified biomarker predicts patients who might benefit from HER2-targeted agents

Study shows precision medicines could aid more breast cancer patients via RNA-targeting

Study shows precision medicines could aid more breast cancer patients via RNA-targeting

New substance could improve efficacy of established breast cancer treatments

New substance could improve efficacy of established breast cancer treatments

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

Two genomic tests help identify most effective treatment for breast cancer patients

Two genomic tests help identify most effective treatment for breast cancer patients

New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

New study shows promise of innovative strategy against HER2-driven lung cancers

New study shows promise of innovative strategy against HER2-driven lung cancers

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer

Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer

Study shows no added benefit of pertuzumab combination in treatment of early breast cancer

Study shows no added benefit of pertuzumab combination in treatment of early breast cancer

Researchers discover potential new approach to block growth of HER2 positive breast cancer

Researchers discover potential new approach to block growth of HER2 positive breast cancer

European Commission approves Pfizer’s first oncology biosimilar

European Commission approves Pfizer’s first oncology biosimilar

Clinical trial results of tucatinib with T-DM1 shows promise in treating HER2+ breast cancer

Clinical trial results of tucatinib with T-DM1 shows promise in treating HER2+ breast cancer

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies